Display options
Share it on

Cancers (Basel). 2020 Dec 11;12(12). doi: 10.3390/cancers12123720.

[No title available]

Cancers

Prospero Civita, Ortenzi Valerio, Antonio Giuseppe Naccarato, Mark Gumbleton, Geoffrey J Pilkington

Affiliations

  1. Brain Tumour Research Centre, Institute of Biological and Biomedical Sciences (IBBS), School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2DT, UK.
  2. School of Pharmacy and Pharmaceutical Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff CF10 3NB, UK.
  3. Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, 56100 Pisa, Italy.
  4. Division of Neuroscience, Department of Basic and Clinical Neuroscience, Institute of Psychiatry & Neurology, King's College London, London SE5 9RX, UK.

PMID: 33322379 PMCID: PMC7763100 DOI: 10.3390/cancers12123720

Abstract

The secondary structures of Scherer commonly known as perineuronal and perivascular satellitosis have been identified as a histopathological hallmark of diffuse, invasive, high-grade gliomas. They are recognised as perineuronal satellitosis when clusters of neoplastic glial cells surround neurons cell bodies and perivascular satellitosis when such tumour cells surround blood vessels infiltrating Virchow-Robin spaces. In this review, we provide an overview of emerging knowledge regarding how interactions between neurons and glioma cells can modulate tumour evolution and how neurons play a key role in glioma growth and progression, as well as the role of perivascular satellitosis into mechanisms of glioma cells spread. At the same time, we review the current knowledge about the role of perineuronal satellitosis and perivascular satellitosis within the tumour microenvironment (TME), in order to highlight critical knowledge gaps in research space.

Keywords: brain tumour; glioblastoma; invasion; perineuronal satellitosis; perivascular satellitosis; satellitosis; tumour heterogeneity

References

  1. PLoS One. 2013;8(3):e59773 - PubMed
  2. Cancer Cell. 2018 May 14;33(5):874-889.e7 - PubMed
  3. Am J Dis Child. 1982 Sep;136(9):852-4 - PubMed
  4. Toxicol Pathol. 2011 Jan;39(1):22-35 - PubMed
  5. Acta Neuropathol. 1979 Mar 15;45(3):177-85 - PubMed
  6. Elife. 2016 Jun 28;5: - PubMed
  7. J Physiol. 2014 Nov 15;592(22):5109-27 - PubMed
  8. Oncotarget. 2015 Sep 22;6(28):24922-34 - PubMed
  9. Proc R Soc Med. 1908;1(Surg Sect):1-13 - PubMed
  10. Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):187-94 - PubMed
  11. Mol Neurobiol. 2018 Aug;55(8):6927-6938 - PubMed
  12. J Clin Oncol. 2015 Apr 1;33(10):1197-213 - PubMed
  13. Oncotarget. 2016 Dec 13;7(50):83701-83719 - PubMed
  14. Exp Neurol. 2014 Oct;260:56-68 - PubMed
  15. Trends Cancer. 2017 Feb;3(2):89-112 - PubMed
  16. Nat Rev Clin Oncol. 2019 Aug;16(8):469-493 - PubMed
  17. Antioxidants (Basel). 2019 May 05;8(5): - PubMed
  18. J Histochem Cytochem. 2018 May;66(5):349-358 - PubMed
  19. Nat Med. 2011 Sep 11;17(10):1269-74 - PubMed
  20. Nature. 2019 Sep;573(7775):532-538 - PubMed
  21. Nature. 2019 Sep;573(7775):526-531 - PubMed
  22. Cell Adh Migr. 2012 Nov-Dec;6(6):509-12 - PubMed
  23. Arch Neurol. 1995 Jul;52(7):717-24 - PubMed
  24. Acta Neuropathol. 2008 Jul;116(1):57-66 - PubMed
  25. J Neuropathol Exp Neurol. 1946 Apr;5:160-4 - PubMed
  26. Dev Dyn. 2019 Jan;248(1):53-64 - PubMed
  27. Cancer Rep (Hoboken). 2019 Dec;2(6):e1185 - PubMed
  28. Adv Exp Med Biol. 2020;1225:71-87 - PubMed
  29. Annu Rev Cell Dev Biol. 2014;30:439-63 - PubMed
  30. Nat Commun. 2016 Nov 15;7:13398 - PubMed
  31. Neuro Oncol. 2020 Jul 05;: - PubMed
  32. Cancer Cell. 2007 Jan;11(1):69-82 - PubMed
  33. Brain. 1950;73(3):291-317 - PubMed
  34. Acta Neuropathol. 2004 Jan;107(1):1-7 - PubMed
  35. Oncotarget. 2016 Aug 30;7(35):56958-56975 - PubMed
  36. Br J Exp Pathol. 1978 Feb;59(1):85-92 - PubMed
  37. J Neurochem. 2008 Apr;105(2):287-95 - PubMed
  38. Int J Cancer. 2012 Jul 1;131(1):173-85 - PubMed
  39. Nature. 2015 Dec 3;528(7580):93-8 - PubMed
  40. Angiogenesis. 2020 Feb;23(1):9-16 - PubMed
  41. Cell Rep. 2019 Mar 19;26(12):3203-3211.e5 - PubMed
  42. Turk Neurosurg. 2015;25(5):796-800 - PubMed
  43. Sci Rep. 2019 Jun 21;9(1):9069 - PubMed
  44. Cancers (Basel). 2011 Aug 10;3(3):3242-78 - PubMed
  45. Amino Acids. 2017 Jan;49(1):21-32 - PubMed
  46. Cells. 2019 Dec 30;9(1): - PubMed
  47. Front Oncol. 2019 Sep 26;9:963 - PubMed
  48. Cancer Sci. 2009 Oct;100(10):1856-62 - PubMed
  49. Cancer Res. 2002 Jan 15;62(2):341-5 - PubMed
  50. Am J Pathol. 2008 Aug;173(2):545-60 - PubMed
  51. Brain. 2014 Feb;137(Pt 2):449-62 - PubMed
  52. Neuro Oncol. 2014 Jul;16(7):896-913 - PubMed
  53. J Neuropathol Exp Neurol. 1956 Apr;15(2):190-5 - PubMed
  54. Int J Mol Sci. 2017 Nov 06;18(11): - PubMed
  55. Cell. 2013 Mar 28;153(1):139-52 - PubMed
  56. J Neurochem. 2009 May;109 Suppl 1:55-62 - PubMed
  57. Epilepsia. 2013 Dec;54 Suppl 9:30-4 - PubMed
  58. Cell. 2019 Aug 8;178(4):835-849.e21 - PubMed
  59. Lancet. 1993 Jun 26;341(8861):1607-10 - PubMed
  60. Front Cell Neurosci. 2013 Apr 16;7:40 - PubMed
  61. Nat Commun. 2014 Jun 19;5:4196 - PubMed
  62. Nature. 2019 Sep;573(7775):539-545 - PubMed
  63. Cancer Res. 2007 Oct 1;67(19):9463-71 - PubMed
  64. Cancer Res. 2013 Dec 1;73(23):7079-89 - PubMed
  65. Cell Commun Signal. 2017 Oct 2;15(1):37 - PubMed
  66. Clin Cancer Res. 2008 Sep 1;14(17):5447-58 - PubMed
  67. Dialogues Clin Neurosci. 2009;11(3):281-95 - PubMed
  68. Neuropathol Appl Neurobiol. 1980 Jul-Aug;6(4):255-66 - PubMed
  69. PLoS One. 2014 Jul 17;9(7):e101402 - PubMed
  70. Cold Spring Harb Symp Quant Biol. 2002;67:267-73 - PubMed
  71. Acta Neuropathol. 2010 Nov;120(5):567-84 - PubMed
  72. J Histochem Cytochem. 2018 Mar;66(3):155-173 - PubMed
  73. Front Oncol. 2019 Jun 07;9:482 - PubMed
  74. Nature. 2017 Sep 28;549(7673):533-537 - PubMed
  75. Acta Neuropathol. 1979 Mar 15;45(3):167-75 - PubMed
  76. Glia. 2011 Aug;59(8):1181-9 - PubMed
  77. Cell. 2015 May 7;161(4):803-16 - PubMed
  78. Nat Med. 2008 Jun;14(6):629-32 - PubMed
  79. Glia. 2009 Sep;57(12):1306-15 - PubMed
  80. Acta Neuropathol. 2016 Jun;131(6):803-20 - PubMed
  81. Biochem Pharmacol. 2020 Jun;176:113814 - PubMed
  82. Angiogenesis. 2016 Apr;19(2):255-6 - PubMed
  83. Hippocampus. 1993 Apr;3(2):239-50 - PubMed
  84. Science. 1999 Jun 18;284(5422):1994-8 - PubMed
  85. Neurobiol Dis. 2006 Apr;22(1):64-75 - PubMed
  86. Neurochem Int. 2012 Aug;61(3):389-96 - PubMed
  87. BMC Cancer. 2013 Jul 17;13:347 - PubMed
  88. Neurobiol Dis. 2000 Aug;7(4):260-9 - PubMed
  89. J Histochem Cytochem. 2015 Jul;63(7):481-93 - PubMed
  90. FASEB J. 2020 Dec;34(12):16464-16475 - PubMed
  91. Top Magn Reson Imaging. 2020 Apr;29(2):115-0 - PubMed
  92. Am J Pathol. 2012 Oct;181(4):1126-41 - PubMed
  93. J Neurosci. 2011 Mar 30;31(13):4858-67 - PubMed
  94. Curr Neurol Neurosci Rep. 2001 May;1(3):225-32 - PubMed
  95. Science. 2019 Aug 9;365(6453):544-545 - PubMed
  96. Cancer Radiother. 2020 Aug;24(5):453-462 - PubMed
  97. Epilepsia. 2012 Aug;53(8):1360-70 - PubMed
  98. Nat Med. 2001 Sep;7(9):1010-5 - PubMed

Publication Types